Milton Werner
Founder presso INHIBIKASE THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Milton H.
Werner is the founder of Inhibikase Therapeutics, Inc. which was founded in 2008.
He holds the title of President, Chief Executive Officer & Director at Inhibikase Therapeutics, Inc. starting in 2012.
Dr. Werner is currently a Member at Winship Cancer Institute.
In the past, he worked as Vice President-Research at Celtaxsys, Inc. in 2007 and as Head-Laboratory of Molecular Biophysics at The Rockefeller University from 1996 to 2007.
Dr. Werner completed his undergraduate degree at the University of Southern California in 1985 and obtained his doctorate degree from the University of California, Berkeley in 1991.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2024 | 889 230 ( 14.37% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Milton Werner
| Società | Posizione | Inizio |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Founder | 01/09/2008 |
| Winship Cancer Institute | Corporate Officer/Principal | - |
Precedenti posizioni note di Milton Werner
| Società | Posizione | Fine |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 01/08/2007 |
| The Rockefeller University | Corporate Officer/Principal | 01/06/2007 |
Formazione di Milton Werner
| University of Southern California | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Winship Cancer Institute |
- Borsa valori
- Insiders
- Milton Werner
